SFX by Ex Libris Inc.

Title:	Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule
Source:	Science [0036-8075] Cheng, J yr:1994

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Bogner, C Bogner C. "Making Sense in Hypercompetitive Environments: A Cognitive Explanation for the Persistence of High Velocity Competition." Organization science 11.2 (2000): 212-226.
description	2.	Suda, T. "Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing." The Journal of experimental medicine 186.12 (1998): 2045-50.
description	3.	Siegel, R M M. "The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity." Nature immunology 1.6 (2000): 469-74.
description	4.	Anderson, R L M. "A novel orthotopic model of breast cancer metastasis to bone." Clinical & experimental metastasis 17.2 (1999): 163-170.
description	5.	Kashmiri, Syed V S V. "SDR grafting--a new approach to antibody humanization." Methods 36.1: 25-34.
description	6.	Elsbach, Pamela D. "Identifying situated cognition in organizations." Organization science 16.4 (2005): 422-433.
description	7.	McNamara, G. "Same as it ever was: the search for evidence of increasing hypercompetition." Strategic management journal 24.3 (2003): 261-278.
description	8.	Barr, PS S. "Adapting to unfamiliar environmental events: A look at the evolution of interpretation and its role in strategic change." Organization science 9.6 (1998): 644-669.
description	9.	Strasser, A. "The Many Roles of FAS Receptor Signaling in the Immune System." Immunity 30.2 (2009): 180-92.
description	10.	By, R. "Organisational change management: A critical review." Journal of Change Management 5.4 (2005): 369-380.
description	11.	Fiol, Brock M. "Consensus, Diversity, and Learning in Organizations." Organization science 5.3 (1994): 403-420.
description	12.	Kaneko, E. "Optimizing Therapeutic Antibody Function: Progress with Fc Domain Engineering." BioDrugs 25.1 (2010): 1-11.
description	13.	Kashmiri, Syed V S V. "SDR grafting of a murine antibody using multiple human germline templates to minimize its immunogenicity." Molecular immunology 41.9 (2004): 863-872.
description	14.	Yarnitsky, D. "Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states." Current opinion in anaesthesiology 23.5 (2010): 611-5.
description	15.	Fujii, I. "[Directed evolution of antibody molecules in phage-displayed combinatorial libraries]." Yakugaku zasshi 127.1 (2007): 91-9.
description	16.	Graca, L. "Reprogramming the Immune System Using Antibodies." Drugs; Education, Prevention and Policy 7: 8-.
description	17.	Mathews, V. "Brain: Gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging." Radiology 211.1 (1999): 257-263.
description	18.	Nagata, S. "Early work on the function of CD95, an interview with Shige Nagata." Cell death and differentiation 11.1 (2004): 23-7.
description	19.	Nagata, S.. "The Fas Death Factor." Science 267.5203 (1995): 1449-1456.
description	20.	Siegel, R M M. "Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations." Science 288.5475 (2000): 2354-7.